Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK14 | Q16539 | 3/20 | 0.39 |
| ▸ | MCHR1 | Q99705 | 14/20 | 0.39 |
| ▸ | CNR1 | P21554 | 1/20 | 0.38 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.38 |
| ▸ | AURKB | Q96GD4 | 1/20 | 0.38 |
| ▸ | DRD2 | P14416 | 1/20 | 0.37 |
| ▸ | ADRA2A | P08913 | 4/20 | 0.37 |
| ▸ | HRH1 | P35367 | 4/20 | 0.37 |
| ▸ | HTR2B | P41595 | 4/20 | 0.37 |
| ▸ | ADRA1A | P35348 | 2/20 | 0.37 |
| ▸ | BCHE | P06276 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6867366 | 1.00 | MAPK14 (0.39) | MAPK14MCHR1CNR1KCNH2AURKB | |
| SCHEMBL6879155 | 0.87 | DRD2 (0.42) | MAPK14DRD2 | |
| SCHEMBL6879152 | 0.87 | DRD2 (0.42) | MAPK14DRD2 | |
| SCHEMBL6868816 | 0.84 | CNR1 (0.39) | MAPK14MCHR1CNR1KCNH2AURKB | |
| SCHEMBL6873416 | 0.84 | MAPK14 (0.40) | MAPK14MCHR1DRD2ADRA2AHRH1 | |
| SCHEMBL6873422 | 0.84 | MAPK14 (0.40) | MAPK14MCHR1DRD2ADRA2AHRH1 | |
| SCHEMBL6879294 | 0.83 | MAPK14 (0.40) | MAPK14MCHR1DRD2ADRA2AHRH1 | |
| SCHEMBL6879291 | 0.83 | MAPK14 (0.40) | MAPK14MCHR1DRD2ADRA2AHRH1 | |
| SCHEMBL6867607 | 0.80 | MAPK8 (0.39) | MAPK14MCHR1DRD2 | |
| SCHEMBL6867614 | 0.80 | MAPK8 (0.39) | MAPK14MCHR1DRD2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1464335-A2 | Quinoline, tetrahydroquinoline and pyrimidine derivatives as mch antagonist | Taisho Pharmaceutical Co. Ltd. (JP) | 2004-10-06 | — | — | EP | disclosed |